BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9330636)

  • 1. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34.
    Zeremski M; Horrigan SK; Grigorian IA; Westbrook CA; Gudkov AV
    Somat Cell Mol Genet; 1997 May; 23(3):233-6. PubMed ID: 9330636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1).
    Garkavtsev I; Demetrick D; Riabowol K
    Cytogenet Cell Genet; 1997; 76(3-4):176-8. PubMed ID: 9186514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions.
    Sanchez-Cespedes M; Okami K; Cairns P; Sidransky D
    Genes Chromosomes Cancer; 2000 Mar; 27(3):319-22. PubMed ID: 10679922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma.
    Krishnamurthy J; Kannan K; Feng J; Mohanprasad BK; Tsuchida N; Shanmugam G
    Oral Oncol; 2001 Apr; 37(3):222-4. PubMed ID: 11287275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and sequence analyses of p33(ING1) gene in myeloid leukemia.
    Ito K; Kinjo K; Nakazato T; Ikeda Y; Kizaki M
    Am J Hematol; 2002 Feb; 69(2):141-3. PubMed ID: 11835353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor suppressor ING1: structure and function.
    Cheung KJ; Li G
    Exp Cell Res; 2001 Aug; 268(1):1-6. PubMed ID: 11461112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.
    Takahashi M; Seki N; Ozaki T; Kato M; Kuno T; Nakagawa T; Watanabe K; Miyazaki K; Ohira M; Hayashi S; Hosoda M; Tokita H; Mizuguchi H; Hayakawa T; Todo S; Nakagawara A
    Cancer Res; 2002 Apr; 62(8):2203-9. PubMed ID: 11956069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.
    Garkavtsev I; Kazarov A; Gudkov A; Riabowol K
    Nat Genet; 1996 Dec; 14(4):415-20. PubMed ID: 8944021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
    Gunduz M; Ouchida M; Fukushima K; Hanafusa H; Etani T; Nishioka S; Nishizaki K; Shimizu K
    Cancer Res; 2000 Jun; 60(12):3143-6. PubMed ID: 10866301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p24/ING1-ALT1 and p47/ING1-ALT2, distinct alternative transcripts of p33/ING1.
    Saito A; Furukawa T; Fukushige S; Koyama S; Hoshi M; Hayashi Y; Horii A
    J Hum Genet; 2000; 45(3):177-81. PubMed ID: 10807544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
    Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of p33ING1 mRNA in lymphoid malignancies.
    Ohmori M; Nagai M; Tasaka T; Koeffler HP; Toyama T; Riabowol K; Takahara J
    Am J Hematol; 1999 Oct; 62(2):118-9. PubMed ID: 10577281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
    Takahashi M; Ozaki T; Todo S; Nakagawara A
    Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer.
    Oki E; Maehara Y; Tokunaga E; Kakeji Y; Sugimachi K
    Cancer Lett; 1999 Dec; 147(1-2):157-62. PubMed ID: 10660101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of a novel gene (ING1L) homologous to ING1, a candidate tumor suppressor.
    Shimada Y; Saito A; Suzuki M; Takahashi E; Horie M
    Cytogenet Cell Genet; 1998; 83(3-4):232-5. PubMed ID: 10072587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The candidate tumour suppressor gene, ING1, is retained in colorectal carcinomas.
    Sarela AI; Farmery SM; Markham AF; Guillou PJ
    Eur J Cancer; 1999 Aug; 35(8):1264-7. PubMed ID: 10615239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer.
    Chen L; Matsubara N; Yoshino T; Nagasaka T; Hoshizima N; Shirakawa Y; Naomoto Y; Isozaki H; Riabowol K; Tanaka N
    Cancer Res; 2001 Jun; 61(11):4345-9. PubMed ID: 11389058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines.
    Campos EI; Cheung KJ; Murray A; Li S; Li G
    Br J Dermatol; 2002 Apr; 146(4):574-80. PubMed ID: 11966686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.
    Hara Y; Zheng Z; Evans SC; Malatjalian D; Riddell DC; Guernsey DL; Wang LD; Riabowol K; Casson AG
    Cancer Lett; 2003 Mar; 192(1):109-16. PubMed ID: 12637159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers.
    Tokunaga E; Maehara Y; Oki E; Kitamura K; Kakeji Y; Ohno S; Sugimachi K
    Cancer Lett; 2000 Apr; 152(1):15-22. PubMed ID: 10754201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.